Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Stuart

Showing results (281-290 of 313) with videos related to

Pageof 32
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
Theranostics|January 6, 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2Kuan-Ying A Huang, Daming Zhou, Tiong Kit Tan, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2014
Application of in situ diffraction in high-throughput structure determination platformsPierre Aller, Juan Sanchez-Weatherby, James Foadi, et al.
NPJ Vaccines|April 2, 2026
Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitopeMarie Bonnet-Di Placido, Helen M E Duyvesteyn, Angela W Steyn, et al.
Cell Reports|March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responsesAiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Cell Host & Microbe|December 18, 2021
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variantsChang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Nature Structural & Molecular Biology|October 16, 2020
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiangdong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Pageof 32

Showing results (281-290 of 313) with videos related to

Sort By:
Pageof 32
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
Theranostics|January 6, 2022
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2Kuan-Ying A Huang, Daming Zhou, Tiong Kit Tan, et al.
Cell Reports. Medicine|May 9, 2024
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinityChang Liu, Daming Zhou, Aiste Dijokaite-Guraliuc, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2014
Application of in situ diffraction in high-throughput structure determination platformsPierre Aller, Juan Sanchez-Weatherby, James Foadi, et al.
NPJ Vaccines|April 2, 2026
Cattle antibodies identify a cross-serotype broadly neutralising foot-and-mouth disease virus epitopeMarie Bonnet-Di Placido, Helen M E Duyvesteyn, Angela W Steyn, et al.
Cell Reports|March 30, 2023
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responsesAiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, et al.
Cell Host & Microbe|December 18, 2021
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variantsChang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Nature Structural & Molecular Biology|October 16, 2020
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Jiangdong Huo, Audrey Le Bas, Reinis R Ruza, et al.
Pageof 32